Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT”) (TSX: MHC.U; MHC.UN) today released its third quarter 2025 results. The financial results of the REIT are prepared in ...

According to experts from Towards Packaging, the global multilingual packaging market is projected to experience steady growth throughout the forecast period, expanding significantly by 2034.Ottawa, ...

Organon (NYSE: OGN) today announced its results for the third quarter ended September 30, 2025. “I am humbled to be working alo ...

Nipomo scored first in double overtime, and Atascadero answered with a touchdown of its own. The Greyhounds elected to go for ...

Expected to receive one of the biggest contracts in MLB history, Kyle Tucker leads the 2025-26 free agent class.